Avalo Therapeutics, Inc. (AVTX)
19.24
+0.24
(+1.26%)
USD |
NASDAQ |
Sep 04, 16:00
19.24
0.00 (0.00%)
After-Hours: 19:16
Avalo Therapeutics Cash and Short Term Investments (Annual) : 98.37M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 98.37M |
| December 31, 2024 | 134.56M |
| December 31, 2023 | 7.416M |
| December 31, 2022 | 13.19M |
| December 31, 2021 | 54.64M |
| December 31, 2020 | 18.96M |
| December 31, 2019 | 11.26M |
| Date | Value |
|---|---|
| December 31, 2018 | 10.66M |
| December 31, 2017 | 2.474M |
| December 31, 2016 | 5.139M |
| December 31, 2015 | 21.22M |
| December 31, 2014 | 11.80M |
| December 31, 2013 | 3.422M |
| December 31, 2012 | 9.520M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Incyte Corp. | 3.581B |
| AbbVie, Inc. | 5.257B |
| Rezolute, Inc. | 167.86M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |